🇺🇸 UTHR — United Therapeutics Corporation
Salud CompraPrecio actual
608,49 USD
Máx. histórico
608,49
0 días
Split 2:1 del 23/09/2009
Caída desde máximo
En máximo
Rango 52 semanas
432,53 – 614,23
Variación hoy
+1,19%
Cierre anterior
601,32
Rango de hoy
578,28 – 614,23
Volumen hoy
908.530
Peor caída histórica
-93,18%
12/07/2000 → 10/12/2001
Recuperado en 3311 días
Volatilidad anualizada ⓘ
46,95%
- Nombre completo
- United Therapeutics Corporation
- Divisa
- USD
- Mercado
- NasdaqGS
- Sector
- Salud
- Industria
- Drug Manufacturers - Specialty & Generic
- Empleados
- 1.400
- PER ⓘ
- 21,57 (puede no estar actualizado)
- Dividend yield
- 0,00% (puede no estar actualizado)
- Precio objetivo analistas
- 670,93 USD (puede no estar actualizado)
- Primera cotización
- 17/06/1999
- Precio actualizado
- hace 20 horas
United Therapeutics Corporation engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. It offers Tyvaso DPI, an inhaled dry powder via pre-filled and single-use cartridges; Nebulized Tyvaso, an inhaled solution via ultrasonic nebulizer; Remodulin (treprostinil) injection to treat patients with pulmonary arterial hypertension to diminish symptoms associated with exercise; Orenitram, a tablet dosage form of treprostinil, to delay disease progression and improve exercise capacity in PAH patients; and Adcirca, an oral PDE-5 inhibitor to enhance the exercise ability in PAH patients. It also markets and sells Unituxin (dinutuximab) injection, a monoclonal antibody for high-risk neuroblastoma; and Remunity Pump, which contains a pump and separate controller for Remodulin. In addition, it is involved in developing RemunityPRO Pump and Ralinepag for the treatment of PAH;and Nebulized Tyvaso, for the treatment of idiopathic pulmonary fibrosis, as well as xenografts, which are development-stage organ products. Further, it provides preclinical products, including EVLP/CLES, for lung transplant; UKidney, UHeart, UThymoKidney, a development-stage gene-edited porcine kidneys and hearts for xenotransplantation; ULobe, for allogeneic regenerative medicine; ULung, for autologous regenerative medicine; IVIVA Kidney, for autologous regenerative medicine; miroliver, for allogeneic regenerative medicine; and mirokidney, for allogeneic regenerative medicine. It has licensing and collaboration agreements with DEKA Research & Development Corp. to develop a semi-disposable system for the subcutaneous delivery of treprostinil; MannKind Corporation to develop and license treprostinil inhalation powder and the Dreamboat device; and Arena Pharmaceuticals, Inc. to develop Ralinepag. The company was founded in 1996 and is headquartered in Silver Spring, Maryland.
| Fecha | Ratio |
|---|---|
| 23/09/2009 | 2:1 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 19/04/2017 | 121,56 | 122,22 | 120,63 | 120,79 | -0,24% | 1,31% | 511.400 |
| 18/04/2017 | 120,80 | 121,55 | 119,54 | 121,08 | -0,12% | 1,66% | 365.600 |
| 17/04/2017 | 121,69 | 122,47 | 120,50 | 121,23 | -0,25% | 1,62% | 439.900 |
| 13/04/2017 | 122,41 | 123,37 | 121,37 | 121,53 | -0,34% | 1,63% | 351.100 |
| 12/04/2017 | 122,41 | 123,54 | 121,31 | 121,95 | +0,14% | 1,82% | 424.800 |
| 11/04/2017 | 122,68 | 124,04 | 120,99 | 121,78 | -0,38% | 2,49% | 737.200 |
| 10/04/2017 | 122,53 | 124,66 | 122,10 | 122,24 | -0,24% | 2,09% | 437.000 |
| 07/04/2017 | 122,23 | 123,13 | 121,90 | 122,53 | +0,43% | 1,01% | 571.500 |
| 06/04/2017 | 123,29 | 124,28 | 120,97 | 122,00 | -0,99% | 2,68% | 790.100 |
| 05/04/2017 | 124,46 | 126,78 | 122,84 | 123,22 | -0,99% | 3,17% | 684.200 |
| 04/04/2017 | 123,26 | 125,47 | 122,45 | 124,45 | +0,40% | 2,45% | 719.000 |
| 03/04/2017 | 121,50 | 129,35 | 121,23 | 123,96 | -8,44% | 6,68% | 2.115.000 |
| 31/03/2017 | 136,93 | 140,40 | 133,07 | 135,38 | -0,71% | 5,35% | 977.800 |
| 30/03/2017 | 135,60 | 137,50 | 132,13 | 136,35 | -1,74% | 3,96% | 810.200 |
| 29/03/2017 | 141,13 | 141,77 | 138,61 | 138,76 | -1,72% | 2,24% | 427.500 |
| 28/03/2017 | 139,85 | 141,82 | 139,68 | 141,19 | +0,49% | 1,53% | 317.200 |
| 27/03/2017 | 138,85 | 141,70 | 138,85 | 140,50 | +0,32% | 2,05% | 348.800 |
| 24/03/2017 | 139,83 | 141,49 | 138,50 | 140,05 | +0,66% | 2,14% | 386.300 |
| 23/03/2017 | 139,08 | 141,36 | 137,63 | 139,13 | -0,17% | 2,68% | 427.800 |
| 22/03/2017 | 139,11 | 141,24 | 138,45 | 139,37 | +0,79% | 2,01% | 416.400 |
| 21/03/2017 | 141,65 | 142,94 | 138,04 | 138,28 | -2,28% | 3,46% | 443.000 |
| 20/03/2017 | 141,44 | 142,75 | 140,07 | 141,51 | -0,40% | 1,89% | 317.000 |
| 17/03/2017 | 138,32 | 142,48 | 138,32 | 142,08 | +2,14% | 3,01% | 1.193.700 |
| 16/03/2017 | 143,26 | 144,50 | 137,07 | 139,11 | -4,74% | 5,19% | 890.400 |
| 15/03/2017 | 145,18 | 147,10 | 144,69 | 146,03 | +0,34% | 1,66% | 555.600 |
| 14/03/2017 | 149,85 | 150,49 | 145,06 | 145,53 | -3,37% | 3,62% | 595.700 |
| 13/03/2017 | 149,31 | 151,16 | 148,03 | 150,60 | +0,77% | 2,10% | 658.700 |
| 10/03/2017 | 146,10 | 149,71 | 146,10 | 149,45 | +2,06% | 2,47% | 722.100 |
| 09/03/2017 | 147,45 | 149,15 | 145,04 | 146,44 | -0,36% | 2,79% | 341.800 |
| 08/03/2017 | 145,77 | 149,07 | 145,77 | 146,97 | +1,37% | 2,26% | 487.700 |